Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
DURABILITY ILIAC1 was conducted to confirm the safety and effectiveness of primary stenting using the EverFlex™ and Protégé™ GPS™ self-expanding stent systems for the treatment of lesions in the common and external iliac arteries.
Results of DURABILITY ILIAC study with Protégé GPS Stent:
Faries, P. Nine-Month Outcomes of DURABILITY ILIAC Trial. VIVA. 2014.